# A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain Metastases

> **NCT01551680** · PHASE1 · TERMINATED · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 3 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **RADIATION:** Radiation combined with iniparib (BSI-201)

## Key facts

- **NCT ID:** NCT01551680
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** end of study of this product
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551680, "A Trial Evaluating Concurrent Whole Brain Radiotherapy and Iniparib in Multiple Non Operable Brain Metastases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01551680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*